COXSACKIEVIRUSES
|
Structure
& Property |
Transmission |
Pathogenesis |
Clinical
findings |
Laboratory
diagnosis |
Treatment |
|
Family: picorna Genome: single-strand RNA, positive polarity Size: 22-30nm Icosahedral nucleocapsid Nonenveloped Group A: 23 serotypes Group B: 6 serotypes |
Transmitted primarily by fecal-oral route and respiratory secretions. Replicate in the oropharynx and intestinal tract. Humans are only natural hosts. Immunity is provided by type-specific IgG antibody |
Group A viruses infect mainly the skin and mucous membranes. Group B viruses cause disease in various organs such as the heart, pleura, pancreas and liver. Both group A and B affect meninges and motor neurons to cause paralysis. Disseminate via bloodstream to other sites from oropharynx and gut. |
Group
A: Herpangina: - fever - sore throat - tender vesicles in oropharynx Hand-foot-mouth disease: - vesicular rash on hands and feet. - ulcerations in mouth - mainly in children. Myositis: flaccid paralysis. Group
B: Bornholm disease: - fever - severe chest pain due to inflammation of intercostal muscles. Myocarditis and pericarditis: - fever - chest pain - signs of congestive failure. Both
groups cause: - aseptic meningitis - upper respiratory infections - minor febrile illnesses |
Diagnosis: - viral isolation in cell culture or suckling mice. - rise in antibody titer Isolation: - feces - throat swab Serologic tests are of little value. Inoculate: - suckling mice - group A coxsackieviruse cause flaccid paralysis due to myositis. - group B coxsackieviruses cause spastic paralysis due to cerebral lesions. - look out for signs of disease. ELISA test used to detect IgM to group B coxsackieviruses. PCR can be used to detect viral RNA in tissues and CSF. |
No antiviral drug therapy or passive immunization is available. |